The Next Stage

The Boston-based Partners HealthCare System plans to implement whole-genome sequencing and interpretation of that data for its hospitals next month, The Boston Globe reports. Its nine hospitals include Massachusetts General Hospital and Brigham and Women's Hospital. The Globe adds that the service is expected to cost about $9,000.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Related Posts

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.